bpc 157 fda warning unapproved peptide safety FDA's Overreach on Compounded Peptides fda warning bpc-157 unapproved peptide

Because peptide therapy is considered an investigational wellness and regenerative treatment, it is not covered by health insurance

This matters practically for EU research teams because most pre-clinical peptide research protocols require repeated dosing over days or weeks from the same reconstituted stock and the cost, time, and wastage of reconstituting fresh vials for every single administration makes unpreserved water impractical as a primary reconstitution solvent for the majority of peptide research applications

Yet, many of us may be deficient in this micronutrient and not even know it

Using a 29 to 31 gauge needle, allowing the solution to reach room temperature, and injecting slowly all minimize discomfort